FMC unveils strategic plan: 2024 rev $4.65-$4.85B, 2026 rev $5.5-$6.0B, asset review

FMC CORP

Preliminary 2024 outlook: revenue $4.65B-$4.85B, adj EBITDA $1.025B-$1.125B, FCF conversion >100%.
2026 goals: revenue $5.5B-$6.0B, adj EBITDA $1.3B-$1.5B.
Strategic review of non-core assets, including potential sale of Global Specialty Solutions (non-crop line).
2033 revenue aspiration: ~$2B from Plant Health, ~$2B from four new active ingredients in R&D pipeline.
New net leverage target of ~2x adjusted EBITDA over next 18-24 months.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.